Improving Outcomes and Reducing Costs with ICS Monotherapy in the Management of Asthma

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive of the live session held at the 2011 Spring Managed Care Forum. If you participated in the live activity, you are not eligible for continuing education credits from this archive.

This activity is valid from October 31, 2011 to October 31, 2012
These presentations require Internet Explorer 5.0 or later, Netscape Navigator 7.0 or later, or Internet Explorer 5.2.2 for Mac.  To Download the latest version of Internet Explorer from the Microsoft web site, click here.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Teva Pharmaceuticals
 
PLEASE CLICK HERE TO VIEW THE PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU: Read the article, answer the post test, complete the evaluation form, and hit submit. A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or you can fax them to Katie Eads at 804-747-5316.

Description
Effective and timely treatment of asthma can both improve patient outcomes and reduce the cost when following these guidelines set forth by NAEPP and NIH. It is imperative that healthcare professionals are brought up to date on these shifting parameters regarding the classification and treatment of asthma patients, so that they can prescribe a treatment course that will both improve outcomes and lower healthcare system costs. This session will review recent studies and comparative effectiveness research to update physicians, nurses and healthcare professionals on the proper use of ICS monotherapies in the management of asthma.

Upon Completion of this activity, participants will be able to:

  • Review guidelines from NAEPP and NIH on the use of ICS Monotherapy in the treatment of Asthma

  • Discuss recent studies and comparative effectiveness research on outcomes and costs associated with ICS treatment versus combination therapies

  • Review the epidemiology and public health burden of asthma

  • Classify asthma severity based on symptoms and diagnosis

  • Explore the role of a medical director and case manager in the management of asthma throughout the healthcare system

Faculty: Dennis Spangler, MD
Principal Partner
Atlanta Allergy Associates

Disclosure:

 Dr. Spangler serves as a consultant from ISTA, Alcon, Teva, and Sunovian Pharmaceuticals. He holds stock in Teva and has received research funding from Alcon. His presentation has been peer reviewed.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA). VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.
   

This activity is supported by an educational grant from Teva Pharmaceuticals
 

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.